NORTHWEST BIOTHERAPEUTICS INC (NWBO) Financials
NWBO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 27.9 million | 93.6 million |
2023-09-30 | 31.5 million | 96.6 million |
2023-06-30 | 28.4 million | 64.1 million |
2023-03-31 | 32.9 million | 65.1 million |
NWBO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -17.4 million | 1.6 million |
2023-09-30 | -14.4 million | 1.6 million |
2023-06-30 | -12.8 million | 278000 |
2023-03-31 | -12.6 million | 933000 |
NWBO Net Income
No data available :(
NWBO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 4.8 million |
2023-09-30 | - | - | 4.5 million |
2023-06-30 | 1.4 million | 15.7 million | 4.8 million |
2023-03-31 | 6.2 million | 16.0 million | 4.7 million |
NWBO Shares Outstanding
NWBO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 418000 | 7.5 million | 8.1 million | - |
2023-09-30 | 437000 | 7.2 million | 7.0 million | - |
2023-06-30 | 1.2 million | 6.2 million | 7.6 million | - |
2023-03-31 | 1.3 million | 6.9 million | 7.0 million | - |
NWBO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 445000 | - |
2023-09-30 | 406000 | - |
2023-06-30 | 201000 | 13.8 million |
2023-03-31 | 880000 | 13.8 million |
NWBO
Price: $0.48
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
P/E Ratio: -9.93
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 1.3 million
Ebitda: -69.1 millionMarket Capitalization: 654.5 million